We are a team of dedicated professionals with expertise in delivering medicines to the body through the inhaled route.  The Leadership Team combined has over 100 years of experience in developing inhaled medicines and bringing these medicines to the U.S. and European markets.  Our purpose at Transpire Bio is framed by two core elements: Access and Innovation.  For common diseases where adequate therapies exist, we seek to expand access to these complex inhaled medicines globally by developing and commercializing lower-cost generic alternatives.  For diseases with few treatment options, we seek to innovate by harnessing existing known mechanisms of action, and dramatically improve the risk-benefit profile of selected molecules by developing these as inhaled therapeutics.  Our understanding of the complexities of inhaled drug-device products will allow us to advance these therapies and improve the health of people around the globe.

Health Care

Life Sciences

Therapeutics

Transpire Bio

Xian-Ming Zeng, Ph.D.

Stuart Loesch

Sunny Zhao

William Schachtner

Michael Goller

M.d. Faaaai

Axel Perlwitz

The Leadership Team at Transpire Bio drives the strategic vision and operational execution of the company, leveraging their extensive expertise in inhaled medicine development. They focus on expanding access to affordable inhaled therapies and fostering innovation in drug formulation and delivery methods for underserved diseases. This team oversees the alignment of regulatory, scientific, and technical operations, ensuring effective collaboration and progress toward improving global health outcomes.

Leadership Team

Scientific Research Team

Project Management Team

Leadership Team

About

Team members

Other teams at Transpire Bio

Scientific Research Team

Project Management Team